JP TSE 4521 Pharmaceutical

Kaken Pharmaceutial Co., Ltd.

科研製薬株式会社

Revenue

¥76.9B

≈ $487.1M

Net income

¥2.1B

≈ $13.6M

Income taxes paid

¥10.7B

≈ $67.5M

Total assets

¥178B

≈ $1.1B

Equity ratio

82.8%

Ranked #360 among listed Japanese companies by corporate taxes paid · effective tax rate 7.3%.

Share price at fiscal year-end: ¥4,141 · market capitalization ¥183B · P/E 73.2 · P/B 1.24

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥76.9B	¥2.1B	¥168M	¥10.7B	¥178B	¥148B	82.8%	EDINET (consol.)
Mar 2025	¥94.0B	¥13.9B	¥5.5B	¥836M	¥193B	¥153B	78.9%	EDINET (consol.)
Mar 2024	¥72.0B	¥8.0B	—	—	¥172B	¥144B	83.8%	EDINET (consol.)
Mar 2023	¥73.0B	¥5.4B	—	—	¥166B	¥137B	82.3%	EDINET (consol.)
Mar 2022	¥76.0B	¥9.5B	—	—	¥165B	¥138B	83.7%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.